1
|
Macek-Jilkova Z, Malov SI, Kurma K, Charrat C, Decaens T, Peretolchina NP, Marche PN, Malov IV, Yushchuk ND. Clinical and Experimental Evaluation of Diagnostic Significance of Alpha-Fetoprotein and Osteopontin at the Early Stage of Hepatocellular Cancer. Bull Exp Biol Med 2021; 170:340-344. [PMID: 33452981 DOI: 10.1007/s10517-021-05063-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2020] [Indexed: 12/31/2022]
Abstract
We evaluated the possibility of using an experimental model of hepatocellular carcinoma to study oncomarkers of primary liver cancer and compared the diagnostic efficacy of alpha-fetoprotein and osteopontin in the experiment and in clinical practice. Experimental studies were performed on a model of hepatocellular carcinoma induced by administration of diethyl nitrosamine to Fisher-344 rats. In addition, the levels of α-fetoprotein and osteopontin were determined in 35 patients with hepatocellular carcinoma detected at stages I-II according to TNM classification. The proposed model of liver cancer in rats reflects the sequence of stages characteristic of hepatocellular carcinoma in humans: liver fibrosis-cirrhosis-cancer. This model is applicable for the study of tumor markers at the early stage of tumor development. Osteopontin was found to have a more powerful diagnostic potential then alpha-fetoprotein.
Collapse
Affiliation(s)
- Z Macek-Jilkova
- Clinique Universitaire d'Hépato-gastroentérologie, Pôle Digidune, CHU Grenoble Alpes, La Tronche, France.,Institute for Advanced Biosciences, Research Center, University Grenoble-Alpes, Grenoble/Inserm U 1209/CNRS 5309, La Tronche, France
| | - S I Malov
- Irkutsk State Medical University, Ministry of Health of the Russian Federation, Irkutsk, Russia.
| | - K Kurma
- Institute for Advanced Biosciences, Research Center, University Grenoble-Alpes, Grenoble/Inserm U 1209/CNRS 5309, La Tronche, France
| | - C Charrat
- Institute for Advanced Biosciences, Research Center, University Grenoble-Alpes, Grenoble/Inserm U 1209/CNRS 5309, La Tronche, France
| | - T Decaens
- Clinique Universitaire d'Hépato-gastroentérologie, Pôle Digidune, CHU Grenoble Alpes, La Tronche, France.,Institute for Advanced Biosciences, Research Center, University Grenoble-Alpes, Grenoble/Inserm U 1209/CNRS 5309, La Tronche, France
| | - N P Peretolchina
- Irkutsk State Medical University, Ministry of Health of the Russian Federation, Irkutsk, Russia
| | - P N Marche
- Institute for Advanced Biosciences, Research Center, University Grenoble-Alpes, Grenoble/Inserm U 1209/CNRS 5309, La Tronche, France
| | - I V Malov
- Irkutsk State Medical University, Ministry of Health of the Russian Federation, Irkutsk, Russia
| | - N D Yushchuk
- A. I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of the Russian Federation, Moscow, Russia
| |
Collapse
|